The safety trial for the cannabis cream for psoriasis is actually in the FDA clinical trials database. While the efficacy trials in Israel should have been adequate to show safety, I believe this safety trial was something the FDA wanted to see to permit sales in the U.S. even if it's to be considered cosmetic.
So how exactly are they going into the US market without FDA approval.
If OWCP is going to make claims of mitigating some dermatological problems - they will certainly need FDA approval.
Of course OWCP is selling shares not any products.
Most here invested in OWCP thinking they owned patents but the reality is that OWCP doesn't own anything proprietary.
The topical cream to treat psoriasis that is infused with CBD would be worthless - CBD products made from hemp oil - that is THC levels below 0.3% are very low quality - obtaining CBD using a extraction process of the whole plant is by far a higher quality of CBD.
The terpenes found in the whole plant is thought to be responsible for the increased medicinal efficacy of CBD.
News 
Market Data 
Discover 
AI
